Which has the lower trailing P/E, ABBV or NVS?

NVS has the lower trailing P/E: ABBV trades at 74.05 and NVS at 21.27. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or NVS?

Over the past five years, ABBV grew revenue faster — ABBV at a 3.69% CAGR versus NVS at 1.53%.

Does ABBV or NVS pay a bigger dividend?

ABBV yields 2.60% and NVS yields 3.36% based on trailing dividends and the latest price.

Is ABBV or NVS more profitable?

NVS runs the higher net margin — ABBV at 9.81% versus NVS at 22.93%.

How have ABBV and NVS total returns compared?

Over the past 10 years, ABBV delivered 20.17% and NVS delivered 11.98% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Novartis AG (NVS)

A side-by-side comparison of AbbVie Inc. and Novartis AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 4, 2026. Differences are shown without an overall score or investment verdict.

ABBV

AbbVie Inc.

$464.35B

$262.82HealthcareDelayed quote: Oct 2, 2026, 4:02 PM EDT

NVS

Novartis AG

$268.00B

$141.00HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — ABBV vs NVS

growth of $100 · dividends reinvested · last 10y

ABBV +526.9% (+20.1%/yr)NVS +209.1% (+11.9%/yr)ABBV compounded faster over this window

ABBV NVS

ABBV vs NVS: by the numbers

•ABBV is the larger company ($464.35B vs $268.00B market cap).
•NVS trades at the lower trailing earnings multiple (21.27 vs 74.05 P/E), one valuation lens rather than an overall verdict.
•NVS converts more revenue to profit (22.93% vs 9.81% net margin).
•ABBV grew revenue faster over the past five years (3.69% vs 1.53% CAGR).
•NVS pays the higher dividend yield (3.36% vs 2.60%).

Metrics side by side

Valuation

Metric	ABBV	NVS
P/E ratio	74.05	21.27
Forward P/E	18.71	16.01
PEG ratio	N/A	1.38
P/S ratio	7.21	4.82
P/B ratio	N/A	6.45
EV / EBITDA	19.72	13.85
FCF yield	3.92%	5.90%

Profitability

Metric	ABBV	NVS
Gross margin	71.48%	74.44%
Operating margin	29.32%	30.54%
Net margin	9.81%	22.93%
ROE	N/A	30.71%
ROIC	13.46%	13.93%

Dividends

Metric	ABBV	NVS
Dividend yield	2.60%	3.36%
Payout ratio	192.43%	71.50%

Growth (annualized)

Metric	ABBV	NVS
Revenue CAGR (5Y)	3.69%	1.53%
EPS CAGR (5Y)	-2.79%	15.42%
FCF CAGR (5Y)	1.19%	8.92%
Total return CAGR (5Y)	23.69%	16.94%

Some values include inputs from SEC filing.

Frequently asked

Which has the lower trailing P/E, ABBV or NVS?: NVS has the lower trailing P/E: ABBV trades at 74.05 and NVS at 21.27. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or NVS?: Over the past five years, ABBV grew revenue faster — ABBV at a 3.69% CAGR versus NVS at 1.53%.
Does ABBV or NVS pay a bigger dividend?: ABBV yields 2.60% and NVS yields 3.36% based on trailing dividends and the latest price.
Is ABBV or NVS more profitable?: NVS runs the higher net margin — ABBV at 9.81% versus NVS at 22.93%.
How have ABBV and NVS total returns compared?: Over the past 10 years, ABBV delivered 20.17% and NVS delivered 11.98% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full NVS analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Novartis AG P/E ratio AbbVie dividend yield Novartis AG dividend yield AbbVie ROE Novartis AG ROE AbbVie operating margin Novartis AG operating margin AbbVie revenue growth Novartis AG revenue growth AbbVie free cash flow Novartis AG free cash flow

AbbVie & Novartis AG appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest ROE Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 4, 2026.